Torsatropin

Drug / MedicationMentioned in 1 video

The first CETP inhibitor developed by Pfizer, which not only failed to show benefit in reducing cardiovascular disease but also led to increased mortality due to off-target effects.

Videos Mentioning Torsatropin

240 ‒ The confusion around HDL and its link to cardiovascular disease | Dan Rader, M.D.

240 ‒ The confusion around HDL and its link to cardiovascular disease | Dan Rader, M.D.

Peter Attia MD

The first CETP inhibitor developed by Pfizer, which not only failed to show benefit in reducing cardiovascular disease but also led to increased mortality due to off-target effects.